The FDA tentatively approved Wockhardt's donepezil hydrochloride, a generic version of Eisai and Pfizer's Alzheimer's disease medicine Aricept. Wockhardt intends to launch its product May 28.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||